{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:17:04Z","timestamp":1790371024224,"version":"4.1.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Modern Rheumatology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.3109\/s10165-010-0406-3","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T15:19:38Z","timestamp":1388675978000},"page":"343-351","source":"Crossref","is-referenced-by-count":115,"title":["Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis"],"prefix":"10.1093","volume":"21","author":[{"given":"Takao","family":"Koike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeko","family":"Inokuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnosuke","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takunari","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Freundlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Suzukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,1,2]]},"reference":[{"issue":"6","key":"CIT0002","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/1529-0131(200106)44:6<1234::AID-ART213>3.0.CO;2-R","volume":"44","author":"Pincus T","year":"2001","journal-title":"Premature mortality in patients with rheumatoid arthritis: evolving concepts. Arthritis Rheum"},{"issue":"2","key":"CIT0003","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","volume":"46","author":"American College of Rheumatology Subcommittee on Rheuma-toid Arthritis Guidelines","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"CIT0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2005.044354","volume":"66","author":"Combe B","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"CIT0006","first-page":"44","volume":"38","author":"Prevoo ML","year":"1995","journal-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum"},{"issue":"9636","key":"CIT0007","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","volume":"372","author":"Emery P","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"CIT0008","first-page":"26","volume":"54","author":"Breedveld FC","year":"2006","journal-title":"The PREMIER study: a mul-ticenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.013052"},{"issue":"11","key":"CIT0010","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/ard.2005.043299","volume":"65","author":"van Riel PL","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"CIT0012","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/art.22718","volume":"56","author":"van der Bijl AE","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"CIT0013","first-page":"478","volume":"130","author":"Moreland LW","year":"1999","journal-title":"Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med"},{"issue":"4","key":"CIT0014","first-page":"253","volume":"340","author":"Weinblatt ME","year":"1999","journal-title":"A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med"},{"issue":"6","key":"CIT0015","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/art.10308","volume":"46","author":"Genovese MC","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"9410","key":"CIT0016","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(04)15640-7","volume":"363","author":"Klareskog L","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"CIT0017","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3899\/jrheum.080791","volume":"36","author":"Koike T","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"CIT0018","first-page":"63","volume":"16","author":"Miyasaka N","year":"2006","journal-title":"Guidelines for the proper use of etanercept in Japan. Mod Rheumatol"},{"key":"CIT0019","first-page":"659","volume":"140","author":"Steinbrocker","year":"1949","journal-title":"Therapeutic criteria for rheumatoid arthritis. JAMA"},{"issue":"1","key":"CIT0022","first-page":"34","volume":"39","author":"van Gestel AM","year":"1996","journal-title":"Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/ International League Against Rheumatism Criteria. Arthritis Rheum"},{"issue":"2","key":"CIT0023","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/ard.2004.023473","volume":"64","author":"Feltelius N","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.043166"},{"issue":"2","key":"CIT0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard.2007.072967","volume":"67","author":"Takeuchi T","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"CIT0026","first-page":"185","volume":"22","author":"Weaver AL","year":"2006","journal-title":"Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry. Curr Med Res Opin"},{"issue":"1","key":"CIT0027","first-page":"169","volume":"22","author":"Gibofsky A","year":"2006","journal-title":"Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study. Curr Med Res Opin"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/s10165-010-0406-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:56:31Z","timestamp":1642560991000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/21\/4\/343-351\/6315679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":22,"aliases":["10.1007\/s10165-010-0406-3"],"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,1,2]]},"published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.3109\/s10165-010-0406-3"],"URL":"https:\/\/doi.org\/10.3109\/s10165-010-0406-3","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}